Boc-Phe-(R)-Phe-OH

Boc-Phe-(R)-Phe-OH is a Boc-protected phenylalanine-containing dipeptide acid building block featuring an (R)-configured stereogenic center within the second residue. The combination of a peptide-grade backbone with a defined stereochemical motif makes it a practical intermediate for assembling stereochemically controlled peptide segments in both research and custom synthesis workflows. As a protected amino acid derivative, it is typically used as a condensed fragment where the Boc group serves to direct N-terminal compatibility during downstream peptide coupling and fragment assembly.

1. Stereocontrolled Peptide Fragments

Boc-Phe-(R)-Phe-OH is used by peptide synthesis groups to build stereochemically defined peptide segments where the (R)-configured residue must be preserved through fragment condensation. Researchers preparing constrained or stereochemically annotated peptide libraries rely on this type of dipeptide acid to introduce both phenylalanine side chains while maintaining a specific chiral configuration at the designated position. The Boc-protected N-terminus supports controlled stepwise assembly, enabling fragment coupling strategies that are common in custom peptide manufacturing and medicinal chemistry lead-optimization programs.

2. Medicinal Chemistry Lead Optimization

Boc-Phe-(R)-Phe-OH is frequently selected in medicinal chemistry for the preparation of peptide-like intermediates used in structure-activity relationship (SAR) studies. Teams developing peptidomimetic scaffolds, protease-sensitive peptide analogs, or stereochemically tuned binding motifs often require dipeptide fragments that carry both aromatic side chains and a defined stereochemical element for consistent SAR comparisons. As a protected dipeptide acid building block, it fits into workflows where stereochemistry and sequence fidelity are critical for downstream biological assay development and chemical series synthesis, while keeping the fragment stable for handling and purification during iterative design cycles.

3. Complex Peptide Segment Assembly

Boc-Phe-(R)-Phe-OH serves as a reliable building block for assembling longer peptide sequences via segment condensation approaches, particularly when a specific dipeptide motif must be introduced as a single, pre-characterized unit. Peptide chemistry laboratories use such protected dipeptide acids to reduce the number of coupling steps and to improve reproducibility when constructing multi-residue targets, including labeled or modified peptide constructs where sequence integrity must be maintained. The presence of a Boc-protected N-terminus and a carboxylic acid functionality supports its role as a defined fragment in iterative coupling and purification workflows used for complex peptide synthesis.

4. Chiral Intermediate For Analog Synthesis

Boc-Phe-(R)-Phe-OH is also used as a chiral intermediate for preparing stereochemically defined analogs where the (R) configuration is a key variable. Chemical biology and medicinal chemistry teams incorporate such chiral dipeptide fragments into analog panels to evaluate how stereochemical presentation of aromatic residues influences conformational preferences and chemical reactivity outcomes during later derivatization steps. In these workflows, the protected dipeptide acid format provides a convenient, isolable unit that can be carried through intermediate stages of peptide or peptidomimetic synthesis while preserving the stereochemical information required for systematic analog generation.

1. Multifunctional peptide-oligonucleotide conjugate promoted sensitive electrochemical biosensing of cardiac troponin I

2. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum

3. Tachykinin-related peptides modulate immune-gene expression in the mealworm beetle Tenebrio molitor L

4. Characterization of Novel P-Selectin Targeted Complement Inhibitors in Murine Models of Hindlimb Injury and Transplantation

5. Effect of Probiotic Lactobacillus plantarum on Streptococcus mutans and Candida albicans Clinical Isolates from Children with Early Childhood Caries